CAS 1052087-90-7

PSB 0739

Description:

PSB 0739, identified by its CAS number 1052087-90-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular formula, structure, and physical properties may vary, compounds like PSB 0739 are often evaluated for their biological activity, solubility, stability, and interaction with biological targets. Typically, such compounds are studied for their efficacy in modulating specific pathways or receptors, which may have implications in treating various diseases. The safety profile, including toxicity and pharmacokinetics, is also crucial for understanding its potential as a drug candidate. As research progresses, detailed information regarding its synthesis, mechanism of action, and clinical relevance may become available, contributing to the broader understanding of its role in pharmaceutical development. For precise data, including experimental results and applications, consulting scientific literature or databases is recommended.

Formula: C₂₆H₂₀N₃NaO₈S₂

Synonyms:

• PSB 0739
• PSB 0739, CID59448166
• 1-Amino-9,10-dihydro-9,10-dioxo-4-[[4-(phenylamino)-3-sulfophenyl]amino]-2-anthracenesulfonic acid sodium salt
• sodium 1-amino-9,10-dioxo-4-{[4-(phenylamino)-3-[(sodiooxy)sulfonyl]phenyl]amino}-9,10-dihydroanthracene-2-sulfonate

PSB-0739

CAS: 1052087-90-7

PSB-0739

Purity: ≥95%

Molecular weight: 609.54g/mol

Ref: 54-BUP22203

PSB-0739

CAS: 1052087-90-7

PSB-0739 Selective platelet P2Y12 receptor antagonist characterized by competitive binding with antithrombotic and platelet aggregation modulating effects.

Formula: C₂₆H₁₇N₃Na₂O₈S₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 609.54

Ref: TM-T23195

PSB 0739

CAS: 1052087-90-7

PSB 0739 is a potent and selective adenosine receptor antagonist. It binds to the p2 receptor, which is a G-protein coupled receptor involved in cell signaling. PSB 0739 has been shown to inhibit contractility of bladder cells and granule cells, as well as inhibiting the release of noradrenaline from adrenergic nerve terminals. This compound also inhibits the activation of cardiac myocytes by increasing cytosolic calcium concentrations. PSB 0739 also blocks the clopidogrel-induced platelet aggregation in vitro and reduces platelet thrombus formation in vivo. PSB 0739 has been shown to block the binding of adenosine to A1 and A2A receptors, but does not bind to other adenosine receptors such as A3 or A4 receptors.

Formula: C₂₆H₁₇N₃Na₂O₈S₂

Purity: Min. 95%

Molecular weight: 609.5 g/mol

Ref: 3D-CSB08790